What is enoxaparin 40 mg injection used for?
Pharmaceutical Product Monograph: Enoxaparin Sodium (40 mg / 0.4 mL)
In the pharmaceutical industry, Enoxaparin is a Low Molecular Weight Heparin (LMWH) derived from porcine intestinal mucosa. As a pharmacist and manufacturer, I view this molecule as the “Gold Standard for Prophylaxis”—it is technically engineered to have a higher ratio of Anti-Factor Xa to Anti-Factor IIa activity compared to Unfractionated Heparin (UFH), providing a more predictable and safer anticoagulation profile.
At your WHO-GMP facility in Mumbai, Enoxaparin 40 mg is likely your highest-volume LMWH SKU. While the 80 mg dose is used for treating existing clots, the 40 mg (4,000 IU) dose is the universal prophylactic dose used to prevent clots from forming in high-risk patients.
Therapeutic Profile: Primary Indications
Enoxaparin 40 mg is primarily indicated for the prevention of Venous Thromboembolism (VTE).
| Indication | Clinical Context | Technical Rationale |
| Surgical Prophylaxis | Ortho / General Surgery | Standard of Care: Used to prevent DVT in patients undergoing hip or knee replacement or major abdominal surgery. |
| Medical Prophylaxis | Hospitalized Patients | Used for patients with restricted mobility due to acute illness (e.g., heart failure, severe respiratory disease). |
| Hemodialysis | Renal Care | Injected into the arterial line of the dialysis circuit to prevent thrombus (clot) formation in the machine’s filter. |
| DVT Treatment (Lower Weight) | Therapeutic | In patients weighing roughly 40 kg, this may serve as a therapeutic dose ($1 \text{ mg/kg}$), though it is mostly prophylactic. |
| Pregnancy Support | Recurrent Miscarriage | Used “off-label” to prevent placental clotting in women with Antiphospholipid Syndrome (APS). |
Mechanism: Factor Xa Inhibition
Enoxaparin works by enhancing the body’s natural “anticoagulant shield”:
Antithrombin III (ATIII) Activation: Enoxaparin binds to ATIII, a protein that naturally inhibits clotting enzymes.
Specific Targeting: The Enoxaparin-ATIII complex specifically targets and neutralizes Factor Xa.
Cascade Interruption: By neutralizing Factor Xa, the conversion of Prothrombin to Thrombin is blocked. Without Thrombin, Fibrin cannot form, and a stable blood clot cannot be created.
Bioavailability: Technically, 40 mg of Enoxaparin has nearly 100% bioavailability after subcutaneous injection, making it far more reliable than oral anticoagulants in acute hospital settings.
The Pharmacist’s “Technical Warning”
The “Air Bubble” Rule: As a pharmacist, I must remind healthcare providers not to expel the air bubble from the pre-filled syringe (PFS). That nitrogen bubble is technically intended to push the drug deep into the tissue and “seal” the track, preventing the drug from leaking back out and causing painful bruising.
Renal Impairment: Enoxaparin is cleared by the kidneys. For patients with Severe Renal Failure ($CrCl < 30 \text{ mL/min}$), the 40 mg dose is technically too high for prophylaxis and must be reduced to 30 mg.
The “Love Handle” Technique: It must be injected into the anterolateral or posterolateral abdominal wall (subcutaneous fat). Never inject it into a muscle (Intramuscular), as this will cause a massive hematoma.
Interactions: Avoid concurrent use of NSAIDs (like Ibuprofen) or Aspirin unless specifically directed by a cardiologist, as the “double-thinning” effect increases the risk of internal bleeding.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “PFS” Advantage: For international B2B tenders, market your 40 mg SKU in Pre-Filled Syringes with Safety Needle Shields. This is a major technical requirement in 2026 to prevent “needle-stick injuries” among nursing staff.
Biological Origin & Traceability: Ensure your dossier highlights the porcine origin and BSE/TSE-free certification. This is a critical technical hurdle for registration in many Middle Eastern and European markets.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Enoxaparin 40 mg/0.4 mL to support your firm’s registration in international B2B hospital and surgical tenders.